325 Capital LLC
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), 325 Capital LLC reported 13 stock positions worth $285.4 million. Its top holding was American Public Education (APEI) at 20.2% of the portfolio, followed by Astrana Health (ASTH, 16.0%) and Magnite (MGNI, 11.4%). Compared with Q3 2025, it opened 1 new position, added to 4 and reduced 2. The biggest buy was Magnite (MGNI, shares +208%) and the biggest sale Astronics (ATRO, shares −95%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001873893
- Portfolio Value
- $285.4M (Q4 2025)
- SEC Filing
- 0001214659-26-001955 ↗ filed Feb 17, 2026
Holdings Value
Holdings 13 stocks · $285.4M
| APEI American Public Education | 20.24% | 1,528,503 | $57.8M | No change |
| ASTH Astrana Health Inc. | 15.99% | 1,839,076 | $45.6M | Add +54.0% |
| MGNI Magnite Inc. | 11.40% | 2,005,387 | $32.5M | Add +208.5% |
| BLBD Blue Bird Corp. | 11.20% | 679,826 | $32.0M | Reduce -12.1% |
| MPAA Motorcar Parts of America Inc. | 8.73% | 2,018,795 | $24.9M | No change |
| AIOT Powerfleet Inc. | 7.15% | 3,837,410 | $20.4M | Add +5.2% |
| LFCR Lifecore Biomedical Inc. | 6.20% | 2,162,466 | $17.7M | No change |
| SPIR Spire Global Inc. | 4.93% | 1,875,000 | $14.1M | No change |
| DBD Diebold Nixdorf Inc. | 4.60% | 193,401 | $13.1M | New |
| BTMD Biote Corp. Class A | 4.14% | 4,548,127 | $11.8M | No change |
| MULTISENSOR AI HOLDINGS INC | 2.67% | 26,489,912 | $7.6M | Add +182.6% |
| TACT Transact Technologies Inc. | 1.42% | 1,011,789 | $4.0M | No change |
| ATRO Astronics Corp. | 1.33% | 70,000 | $3.8M | Reduce -94.9% |
Portfolio Sells Q3 2025 → Q4 2025
Portfolio Buys Q3 2025 → Q4 2025
| MGNI Magnite Inc. | Add +208.5% | 11.40% | +7.10 |
| ASTH Astrana Health Inc. | Add +54.0% | 15.99% | +5.70 |
| DBD Diebold Nixdorf Inc. | New | 4.60% | +4.60 |
| AIOT Powerfleet Inc. | Add +5.2% | 7.15% | +1.35 |
| MULTISENSOR AI HOLDINGS INC | Add +182.6% | 2.67% | +0.84 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $419.5M | ASTH, MGNI, APEI, BLBD, SPIR |
| Q1 2026 | 12 | $274.5M | APEI, ASTH, BLBD, MGNI, SPIR |
| Q4 2025 | 13 | $285.4M | APEI, ASTH, MGNI, BLBD, MPAA |
| Q3 2025 | 12 | $329.1M | ATRO, APEI, BLBD, ASTH, MPAA |
| Q2 2025 | 11 | $253.3M | APEI, ATRO, BLBD, MPAA, SPIR |
| Q1 2025 | 11 | $241.4M | APEI, ATRO, ASTH, BLBD, AIOT |
| Q4 2024 | 12 | $258.7M | APEI, BLBD, BTMD, ASTH, ATRO |
| Q3 2024 | 11 | $236.2M | ASTH, BLBD, ATRO, APEI, BTMD |
| Q2 2024 | 13 | $238.1M | BLBD, ATRO, BTMD, ASTH, APEI |
| Q1 2024 | 12 | $216.6M | BLBD, ATRO, SGOV, ASTH, BTMD |